# Combined Pulsed-field Ablation (PFA) and Left Atrial Appendage Occlusion Using Watchman Flx or Amulet

Study · id `cardio:ct-nct05560204` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05560204](<https://clinicaltrials.gov/study/NCT05560204>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05560204

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT05560204. Randomized; no masking; primary purpose treatment. Start 2023-01-01 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT05560204, source copy `cardio:ctgov-nct05560204-2026-09-16`, retrieved 2026-10-26)
- Started: 2023-01-01 (actual) (ClinicalTrials.gov record NCT05560204, source copy `cardio:ctgov-nct05560204-2026-09-16`, retrieved 2026-10-26)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT05560204, source copy `cardio:ctgov-nct05560204-2026-09-16`, retrieved 2026-10-26)
- Completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT05560204, source copy `cardio:ctgov-nct05560204-2026-09-16`, retrieved 2026-10-26)
- Countries: Hong Kong SAR China (ClinicalTrials.gov record NCT05560204, source copy `cardio:ctgov-nct05560204-2026-09-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05560204-2026-09-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Combined Pulsed-field Ablation (PFA) and Left Atrial Appendage Occlusion Using Watchman Flx or Amulet
- Acronym: COMPAWA
- Condition: Combined Pulsed-field Ablation (PFA)
- Intervention (Device): Combined Pulsed-field Ablation (PFA) + Left Atrial Appendage Occlusion (LAAO)
- Lead sponsor: Prince of Wales Hospital, Shatin, Hong Kong
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: ed19d73322c06a736a6eb1a1749871e5175a9c8587c76da3337402e0f12568b6
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
